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Abstract The prevalence of antimicrobial resistance
among the commensal microflora was examined in the
Indonesian population inside and outside hospitals. A total
of 3,995 individuals were screened in two major urban
centers. Among Escherichia coli from rectal samples (n=
3,284) the prevalence of resistance to ciprofloxacin and
other classes of antibiotics was remarkably high, especially
in individuals at the time of discharge from hospital.
Staphylococcus aureus isolates (n=361) were often resis-
tant to tetracycline (24.9%), but this was not associated
with hospital stay. Two S. aureus isolates harbored the
mecA gene. Regional differences in resistance rates exist,
suggesting regional differences in selection pressure, i.e.,
antibiotic usage patterns. The results show that antimicro-
bial resistance among commensal E. coli and S. aureus has
emerged in Indonesia.
Introduction
Antimicrobial resistance has become a major health
problem worldwide, both in hospitals and the community
[1–5]. The emergence of antimicrobial resistance is corre-
lated with selective pressure from the use, often inappro-
priate, of antimicrobial agents [1–5] and results in increased
mortality, morbidity, and health care costs [2]. Data on the
epidemiology of antimicrobial resistance is important and
can be drawn from three general sources: surveillance,
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outbreak investigations, and prospective studies [2]. Resis-
tance data may be gathered either from clinical isolates or
from isolates cultured from the commensal microflora of
individuals in the absence of infection [6–9]. Surveillance
of antimicrobial resistance has been reported in many
countries, including developing countries in the Far East
[10–23]. However, resistance data from Indonesia are
limited to bacterial pathogens isolated from patients with
infections, especially diarrheal disease [15–19]. No data
exist on the presence of resistance among potential
pathogens in the commensal flora of Indonesian people.
Such data are relevant, as they should provide a basis for
the selection of empiric use of antimicrobial agents, either
for therapy or for prophylaxis. Therefore, the aim of this
study was to investigate antimicrobial resistance rates
among potential pathogens in the commensal microflora




Two university hospitals, Dr. Soetomo Hospital in Surabaya,
East Java, and Dr. Kariadi Hospital in Semarang, Central
Java, Indonesia, and three primary health centers (two in
Surabaya and one in Semarang) were selected for this study.
Four thousand individuals were targeted to be screened
constituting four different populations in each of the two
cities (500 individuals per population group per city). Group 1
consisted of patients being admitted to the hospital (admission
group), group 2 were patients being discharged from the
hospital (discharge group), group 3 contained ambulatory
patients visiting primary health centers (puskesmas group),
and group 4 consisted of relatives of patients being admitted
to the hospital in each of the two cities (relatives group).
Patients at admission and discharge were selected from four
hospital departments: internal medicine, surgery, obstetrics
and gynecology, and pediatrics. Individuals were excluded
from the study if they were transferred from another hospital,
if they were not accompanied by a family member (admission
group), or if they had been admitted to a hospital within the
previous 3 months (admission group, puskesmas group and
relatives group). Approval of the medical ethics committees
was obtained before the start of the study. Only patients who
had given their informed consent were included.
Bacterial isolation
Rectal and nasal samples were taken with sterile, cotton-
tipped swabs, and these were put in Amies transport medium
(Copan, Brescia, Italy) and transported in closed boxes at
ambient temperature to the laboratory on the same day. All
swabs were cultured within 24 h. Rectal swabs were cultured
on CHROMagar Orientation (Becton Dickinson, Heidelberg,
Germany) for isolation of Escherichia coli [24]. From each
swab, two colonies representing the dominant growth in the
fecal flora were collected. Pink colonies were assumed to be
E. coli and were used for susceptibility testing without
additional identification testing. Nasal swabs were cultured
by using phenol red mannitol agar (Becton Dickinson,
Heidelberg, Germany) for isolation of Staphylococcus aureus.
In the Netherlands, all probable S. aureus isolates were
identified by a latex agglutination test (Staphaurex Plus,
Abbott, Murex, Chatillon, France) and the Vitek 2 system
(bioMérieux, Marcy l’Etoile, France). In case of doubt, an S.
aureus-specific DNA hybridization test (Accuprobe,
Genprobe inc., San Diego, CA, USA) was performed.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing of the isolates was
performed in Indonesia by disk diffusion as recommended
by the Clinical and Laboratory Standards Institute (CLSI;
formerly the NCCLS) [25]. Disks loaded with the following
antimicrobial agents (Oxoid, Basingstoke, UK) were used for
susceptibility testing of E. coli: gentamicin, chloramphenicol,
trimethoprim/sulfamethoxazole, ampicillin, cefotaxime, and
ciprofloxacin. One E. coli isolate per patient was included in
the analysis. Tetracycline, oxacillin, gentamicin, erythromycin,
chloramphenicol, and trimethoprim/sulfamethoxazole disks
were used for susceptibility testing of S. aureus. The
performance of the susceptibility testing was monitored twice
weekly by the quality control strains E. coli ATCC 25922 and
S. aureus ATCC 25923.
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PCR for mecA gene detection
Polymerase chain reaction (PCR) formecA gene detection was
performed with primers MEC1 (5′- AAA ATC GAT GGT
AAA GGT TGG C- 3′) and MEC2 (5′- AGT TCT GCA GTA
CCG GAT TTG C- 3′), which generate a 533-bp product as
described previously [26]. Bacterial DNA was isolated on a
MagNA Pure LC™ with MagNA Pure LC DNA Isolation Kit
III for bacteria and fungi (Roche Molecular Biochemicals,
Mannheim, Germany). DNA concentration was assessed
spectrophotometrically. PCR program was performed under
the following conditions: predenaturation for 4 min at 94°C;
25 cycles of 45 s at 94°C, 45 s at 55°C, and 45 s at 72°C, and
a final extension step of 5 min at 72°C. PCR products were
resolved in a 1% agarose gel in 0.5 Tris-borate + ethylene-
diaminetetraacetate (TBE) stained with ethidium bromide and
visualized under ultraviolet (UV) light. A positive and a
negative control were included in each PCR run.
Statistical analysis
Statistical comparisons of antibiotic resistance between the
strains collected from the four different groups and between
similar groups in the two cities were made by using the chi-
square analyses or Fisher’s exact test (two-tailed). Data
were analyzed by using the statistical software package
SPSS version 11.5 for Windows (SPSS Inc. Chicago, IL,
USA). A p value < 0.05 was considered significant.
Results
A total of 3,995 individuals were screened between July
and October 2001 in Surabaya and between January and
May 2002 in Semarang. We collected 5,535 E. coli strains
from 3,284 individuals and 362 S. aureus isolates from as
many individuals.
Resistance among E. coli
E. coli isolates (3,284) showed considerable levels of
resistance against a number of commonly used antibiotics
(Table 1). For most antimicrobials, the lowest resistance
rates were measured in E. coli isolated from the relatives
group, whereas the highest rates were measured in
patients in the discharge group. For all antimicrobials,
resistance rates on discharge were higher compared with
those in patients on admission, relatives, and patients
visiting a primary health center. Substantial resistance
rates toward chloramphenicol, trimethoprim/sulfa-
methoxazole, and ampicillin were observed among E.
coli cultured from patients visiting primary health centers
compared with E. coli from the relatives group. Resis-
tance toward gentamicin, cefotaxime, and ciprofloxacin
was low on admission to the hospital. However, high
rates of resistance against these latter antibiotics were
found among E. coli cultured from patients at the time of
discharge from the hospital.
Table 1 Antimicrobial resistance rates [n (%)] of Escherichia coli and Staphylococcus aureus from different cohorts in Indonesia
Admission Discharge Relatives Primary health center (puskesmas) Total
E. coli n=822 n=784 n=815 n=863 n=3,284
Gentamicin 32 (3.9)a 141 (18.0)d,e 11 (1.3)c 18 (2.1)b 202 (6.2)
Chloramphenicol 210 (25.5)a 335 (42.7)d,e 64 (7.9)c 95 (11.0)b,f 704 (21.4)
Trimethoprim/sulfamethoxazole 342 (41.7)a 435 (55.5)d,e 164 (20.1)c 209 (24.2)b,f 1,150 (35.0)
Ampicillin 416 (50.6)a 571 (72.8)d,e 162 (19.9)c 271 (31.4)b,f 1,420 (43.2)
Cefotaxime 17 (2.1)a 98 (12.5)d,e 6 (0.7)c 8 (0.9) 129 (3.9)
Ciprofloxacin 48 (5.8)a 173 (22.1)d,e 17 (2.1)c 17 (2.0)b 255 (7.8)
S. aureus n=84 n=98 n=82 n=97 n=361
Tetracycline 29 (34.5) 24 (24.5) 18 (22.0) 19 (19.6)b 90 (24.9)
Oxacillin 0 (0) 2 (0.6) 0 (0) 0 (0) 2 (0.6)
Gentamicin 2 (2.4) 1 (1.0) 0 (0) 1 (1.0) 4 (1.1)
Erythromycin 4 (4.8) 5 (5.1) 1 (1.2) 2 (2.1) 12 (3.3)
Chloramphenicol 12 (14.3) 9 (9.2) 7 (8.5) 6 (6.2) 34 (9.4)
Trimethoprim/sulfamethoxazole 10 (11.9) 7 (7.1)d 7 (8.5) 0 b, f 24 (6.6)
Resistance rates were compared in defined pairs (see a–f), using the chi-square test or Fisher’s exact test, as applicable (p<0.05 was considered
significant)
a Significant difference for admission vs. discharge
b Significant difference for admission vs. puskesmas
c Significant difference for admission vs. relatives
d Significant difference for discharge vs. puskesmas
e Significant difference for discharge vs. relatives
f Significant difference for puskesmas vs. relatives
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Resistance among S. aureus
The rate of nasal carriage of S. aureus was 362 out of 3,995
(9.1%) individuals. One strain of S. aureus did not grow on
the Mueller Hinton agar plate for antimicrobial susceptibility
testing. Overall, 90/361 (24.9%) S. aureus strains were
resistant to tetracycline and 2/361 (0.6%) were resistant to
oxacillin (Table 1). The two oxacillin-resistant strains of S.
aureus harbored the mecA gene. Resistance rates against
tetracycline among patients on admission were higher
compared with rates found in patients visiting the primary
health centers (p=0.022). For trimethoprim/sulfa-
methoxazole, the resistance rates among isolates from
patients on admission, patients on discharge, and from
relatives of patients on admission were higher compared
with the rates among S. aureus isolates from patients
visiting primary health centers (p<0.001, p=0.013, and
p=0.007, respectively).
Geographical differences
When comparing resistance data of E. coli and S. aureus
isolated in Semarang with those isolated in Surabaya, the
overall trends observed were similar. However, some
striking differences became obvious. For E. coli, the
resistance rates among patients at discharge in Semarang
were higher than those observed in Surabaya for all
antibiotics except for gentamicin (data not shown). Also,
more resistance among E. coli was observed in Semarang
compared with Surabaya with regard to ampicillin [792/
1,707 (46.4%) in Semarang vs. 628/1,577 (39.8%) in
Surabaya; p<0.001)] In contrast, chloramphenicol resis-
tance was higher among E. coli isolated from Surabaya
patients on admission [117/389 (30.1%) in Surabaya vs. 93/
433 (21.5%) in Semarang; p=0.005] and likewise when
comparing isolates from their relatives [38/383 (9.9%) in
Surabaya vs. 26/432 (6.0%) in Semarang; p=0.05].
With regard to S. aureus, the rates of resistance to
trimethoprim/sulfamethoxazole in the admission and rela-
tives groups and tetracycline resistance in the discharge
group in Surabaya were much higher than in Semarang
(data not shown).
Discussion
This study is the first population-based study of antimicro-
bial resistance among common pathogenic bacteria in the
commensal microflora of several groups of individuals in
Indonesia. We stress the fact that the strains examined in
the present study were not isolated from clinical materials
as in previous studies but from the normal flora of the
anterior nares and from the rectum of individuals with a
variety of diseases as well as from healthy persons. We
targeted our surveillance of antimicrobial resistance
towards E. coli and S. aureus, as they can be considered
sentinel species of microorganisms for the emergence of
resistance [6–9]. Analyses of possible risk factors for the
carriage of resistant microorganisms, such as demographic,
socioeconomic, disease-related and healthcare-related deter-
minants as well as recent antibiotic use will be described
elsewhere.
We showed that antibiotic resistance rates among E. coli
isolated from patients on discharge from the hospital are
consistently higher than previously described. An earlier
study in Indonesia by US Naval Medical Research Unit #2
(NAMRU-2) [16] showed that resistance rates for ampicil-
lin, chloramphenicol, and trimethoprim/sulfamethoxazole
among clinical isolates of enterotoxigenic E. coli (ETEC)
were higher than in our study. In contrast, our study yielded
higher rates of ciprofloxacin resistance compared with that
study. There are no earlier data about resistance rates of E.
coli against gentamicin and cefotaxime in Indonesia.
However, in a survey performed in Indonesian hospitals
in the late 1990s, 23.3% of E. coli had an extended-
spectrum beta-lactamase phenotype [14].
From a series of studies that were conducted through the
1980s and 1990s in Taiwan, 100% of clinical isolates of E.
coli proved susceptible to fluoroquinolones (norfloxacin,
ofloxacin, and ciprofloxacin) until 1996. By 1996–1997,
20% of E. coli had become resistant to ciprofloxacin, and
48% of patients with ciprofloxacin-resistant E. coli report-
edly had not used any fluoroquinolones [27]. Another study
from Taiwan reported that the ciprofloxacin resistance rate
among E. coli was 11.3% between August and December
1998, [28] 0% in 1998–1999 by the SENTRY surveillance
program, [23] and 46% in 1999 by the National Taiwan
University Hospital study (NTUH) [29]. Data of antimi-
crobial resistance of clinical isolates of E. coli against
ciprofloxacin from other countries have also been reported
by the SENTRY global antimicrobial surveillance program:
61% in Hong Kong, 93% in mainland China, 75% in
Singapore, and 54% in the Philippines [23]. In Korea, the
Korean Nationwide Surveillance of Antimicrobial Resis-
tance Study (KONSAR) reported a rate of 28%, [30], and
the Taiwan Surveillance of Antimicrobial Resistance
(TSAR) reported 12% in Taiwan [31]. Although in all
studies clinical isolates of E. coli were used, it is clear that
fluoroquinolone resistance is now prevalent in most
countries in Asia, including Indonesia. The genetic back-
grounds and virulence characteristics of the Indonesian
fluoroquinolone-resistant E. coli from the present study
have recently been described by Kuntaman et al. [32].
Multiple studies have reported high frequencies of
methicillin-resistant S. aureus (MRSA) among clinical
isolates of S. aureus in Asia. The rate of MRSA among
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clinical S. aureus isolates was more than 50% in Korea in
1997 [11, 33] and more than 60% in Taiwan between 1993
and 1999 [10, 34]. In Japan it was 35.8% in 1987 and has
increased to 67.3% in 1989 [35]. Another study in Japan
showed that the frequency of MRSA was 22–64% in 1988,
22–69% in 1989, and 29–76% in 1990, and increasing
yearly [21]. Furthermore, S. aureus with reduced suscepti-
bility to vancomycin has been found in hospitals in several
Asian countries [36].
In this study, we found that methicillin resistance in S.
aureus was 2/361(0.6%) isolates from Indonesia. These
oxacillin-resistant strains of S. aureus harbored the mecA
gene. This finding suggests that MRSA has not yet gained a
strong foothold in the Indonesian archipelago. Only two of
3,995 (0.05%) persons screened harbored MRSA, which
compares favorably with the 0.84% MRSA carrier rate
found in the same period in a population-based screening
study in the USA [37]. However, as we did not include
clinical strains causing nosocomial infections in this study,
we cannot exclude the possibility that MRSA has emerged
in some hospital settings in Indonesia. Of note, the overall
rate of S. aureus nasal carriage in our study was only 9.1%,
i.e., much lower than the 20% or higher levels generally
found among populations in Western countries [38]. Low
carriage rates of S. aureus among the Indonesian population
may, by itself, reduce or interfere with the spread and
emergence of MRSA variants.
There are no prior data about the prevalence of antibiotic
resistance of commensal S. aureus against tetracycline,
gentamicin, erythromycin, chloramphenicol, and trimetho-
prim/sulfamethoxazole in Indonesia. When we compare our
findings with recent data from Taiwan [39], the prevalence of
antimicrobial resistance among clinical isolates of S. aureus
was higher in Taiwan than in Indonesia. The resistance rates
for tetracycline were 71% and 24.9%, for oxacillin 60% and
0.6%, for gentamicin 51% and 1.1%, for erythromycin 73%
and 3.3%, for chloramphenicol 29% and 9.4%, and for
trimethoprim/sulfamethoxazole 42% and 6.6% in S. aureus
from Taiwan and from Indonesia (this study), respectively.
Antimicrobial resistance profiles of clinical isolates of S.
aureus have also been reported from Korea [22], showing
that the resistance rates of methicillin-sensitive S. aureus
(MSSA) and MRSA against tetracycline were 22% and 90%,
against gentamicin 28% and 95%, against erythromycin 37%
and 98%, and against trimethoprim/sulfamethoxazole 1%
and 9% in MSSA and MRSA, respectively. In contrast to our
study, the Taiwanese and Korean surveillance systems were
based on clinical samples and not on sampling of commensal
flora, as was done in this study. Thus, direct comparison is
not valid, as resistance rates among clinical isolates of S.
aureus may well be higher in Indonesia also.
In conclusion, we show that antimicrobial resistance
among E. coli and S. aureus present in the commensal
microflora of people has emerged in Indonesia. Among E.
coli, the prevalence of resistance to ciprofloxacin and other
antibiotics is remarkably high, especially in individuals
after hospitalization. Although the prevalence of MRSA is
low, tetracycline resistance is common among S. aureus
and not associated with hospital stay. Within Indonesia,
regional differences in resistance rates exist, suggesting
regional differences in selection pressure, i.e., antibiotic
usage patterns. Moreover, for S. aureus, resistance rates of
isolates from patients at discharge from the hospital were
no higher than on admission, whereas these rates in E. coli
were significantly higher on discharge. Therefore, resis-
tance in E. coli appeared to be both community and hospital
associated, whereas resistance in S. aureus seems to be
mainly community derived. This is an important finding for
future strategies that target the containment of antimicrobial
resistance in Indonesia.
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